Related references
Note: Only part of the references are listed.Anatomical and functional changes in neovascular AMD in remission: comparison of fibrocellular and fibrovascular phenotypes
Lea Querques et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group
Richard F. Spaide et al.
OPHTHALMOLOGY (2020)
Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study
Chen Liwen et al.
ACTA OPHTHALMOLOGICA (2020)
Treating neovascular age-related macular degeneration in the era of COVID-19
Fares Antaki et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)
Ophthalmology in the time of COVID-19: experience from Hong Kong Eye Hospital
Stephanie S. L. Cheung et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2020)
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
Leiwen Fu et al.
JOURNAL OF INFECTION (2020)
Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration The RAMPS Study
Kelvin Yi Chong Teo et al.
OPHTHALMOLOGY RETINA (2020)
Update and Recommendations for Ocular Manifestations of COVID-19 in Adults and Children: A Narrative Review
Veena Danthuluri et al.
OPHTHALMOLOGY AND THERAPY (2020)
Proposed algorithm during COVID-19 pandemic for patient management in medical retina clinic
Paolo Corazza et al.
INTERNATIONAL JOURNAL OF RETINA AND VITREOUS (2020)
Retinal findings in patients with COVID-19: Results from the SERPICO-19 study
Alessandro Invernizzi et al.
ECLINICALMEDICINE (2020)
Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
Thomas Wecker et al.
SCIENTIFIC REPORTS (2019)
Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review
Saira Khanna et al.
BMJ OPEN OPHTHALMOLOGY (2019)
NATURAL COURSE OF PATIENTS DISCONTINUING TREATMENT FOR AGE-RELATED MACULAR DEGENERATION AND FACTORS ASSOCIATED WITH VISUAL PROGNOSIS
Jae Hui Kim et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2017)
Recent developments in age-related macular degeneration: a review
Waseem M. Al-Zamil et al.
CLINICAL INTERVENTIONS IN AGING (2017)
Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration
Philipp S. Muether et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
Vascular Endothelial Growth Factor A in Intraocular Vascular Disease
Joan W. Miller et al.
OPHTHALMOLOGY (2013)
Delay to Treatment and Visual Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor for Age-Related Macular Degeneration
Jonathan H. Lim et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity
Philipp Sebastian Muether et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
